HOT NEWS
COAGADEX® Earns Orphan Drug Designation for Rare Bleeding Disorder
Kedrion Biopharma has announced a major step forward in rare disease treatment: its plasma-derived therapy, COAGADEX® (Coagulation Factor X, Human), has received Orphan Drug...
EMA Issues Positive Opinion on Mirdametinib for NF1-Associated Plexiform Neurofibromas
On 22 May 2025, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for mirdametinib...
Kedrion Biopharma Advances COAGADEX for Rare Bleeding Disorder with New FDA Designation and Clinical Trial
Kedrion Biopharma has received Orphan Drug Designation from the U.S. FDA for COAGADEX®, a plasma-derived human coagulation factor concentrate, targeting Acquired Factor X...
Long-Term Benefits of TIBSOVO® in IDH1-Mutated AML: A Summary of the Phase 3 AGILE Trial Results
Servier recently published updated long-term data from the Phase 3 AGILE trial in Blood Advances, confirming the sustained survival benefit of TIBSOVO® (ivosidenib) combined with...
European Commission Approves DARZALEX Faspro for High-Risk Smouldering Multiple Myeloma
On July 23, 2025, the European Commission approved DARZALEX Faspro® (daratumumab), co-formulated with Halozyme's ENHANZE® technology, as monotherapy for adult patients with...
Don't hesitate to contact us ,please click inquiry.
We will be to keep your information strictly confidential
Leave Your Message
DEPARTMENT NAVIGATION
Medicine Updates
    TOP 6 USER FOLLOW
    TOP 1
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
    TOP 2
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in Parkinson's disease.
    TOP 3
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
    Faricimab-svoa(Vabysmo)
    Faricimab-svoa(Vabysmo)
    Treatment of neovascular age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion.
    DatopotamabDeruxtecan-dlnk(Datroway)
    DatopotamabDeruxtecan-dlnk(Datroway)
    Treatment of unresectable or metastatic HR-positive, HER2-negative breast cancer in adults who have received prior endocrine therapy and chemotherapy.
    Vadadustat(Vafseo)
    Vadadustat(Vafseo)
    Treatment of anemia in adults with chronic kidney disease (CKD) who have been on dialysis for at least three months.
    Company Introduction
    Seagull Pharmacy offers a diverse range of medications, including both prescription and over-the-counter drugs. The platform prioritizes medication quality and provides 24/7 services. Whether it's consultation on medication purchases or post-sale support, Seagull Pharmacy strives to deliver meticulous care in every detail, consistently placing customers' needs at the forefront.
    Click here to contact us
    LATEST ARTICLES
    • What Are the Precautions for Ivosidenib (Tibsovo) Administration?
      Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase-1 (IDH1) inhibitor that has demonstrated significant efficacy in the treatment of IDH1-mutated acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and cholangiocarcinoma.
      501
      2025-12-16 13:17:16
    • Dosage and Administration, Recommended Dose of Ivosidenib (Tibsovo)
      Ivosidenib (Tibsovo) is an innovative isocitrate dehydrogenase-1 (IDH1) inhibitor, which represents a breakthrough in the treatment of hematological malignancies and solid tumors.
      501
      2025-12-16 13:15:07
    • What Are the Indications for Ivosidenib (Tibsovo)?
      Ivosidenib (Tibsovo) represents a pivotal breakthrough in the field of precision medicine. By targeting malignant tumors with specific genetic mutations, it offers a novel therapeutic option for patients.
      501
      2025-12-16 13:12:24
    • What Are the Purchase Channels for Ivosidenib (Tibsovo)?
      Ivosidenib (Tibsovo) is a targeted therapy for IDH1-mutant acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma. Its proper acquisition and standardized administration directly impact treatment efficacy and patient safety.
      501
      2025-12-16 13:09:58
    • Adverse Effects of Finerenone
      Finerenone is a novel non-steroidal mineralocorticoid receptor antagonist that plays an important role in the treatment of patients with chronic kidney disease complicated by type 2 diabetes mellitus and specific heart failure.
      502
      2025-12-16 11:24:08
    • What Are the Precautions for Finerenone Administration?
      Finerenone is a novel non-steroidal mineralocorticoid receptor antagonist (nsMRA) that exhibits significant clinical value in the treatment of chronic kidney disease associated with type 2 diabetes mellitus and heart failure. To ensure medication safety, both healthcare professionals and patients need a comprehensive understanding of the precautions and monitoring requirements for this drug.
      501
      2025-12-16 10:56:46
    • Dosage and Administration, Recommended Dose of Finerenone
      ​As a novel non-steroidal mineralocorticoid receptor antagonist (nsMRA), finerenone demonstrates significant value in the treatment of chronic kidney disease complicated with type 2 diabetes mellitus, as well as heart failure with preserved ejection fraction.
      501
      2025-12-16 10:54:18
    • What Are the Indications for Finerenone?
      Finerenone is a novel non-steroidal mineralocorticoid receptor antagonist. By precisely inhibiting aldosterone- and cortisol-mediated fibrosis and inflammatory responses in the kidneys and cardiovascular system, it provides an innovative therapeutic option for patients with chronic kidney disease (CKD) and specific heart failure (HF).
      500
      2025-12-16 10:44:20
    • What Are the Purchase Channels for Finerenone?
      The significance of finerenone in the treatment of chronic kidney disease (CKD) complicated with type 2 diabetes mellitus (T2DM) and specific heart failure is increasingly prominent. How to obtain the drug properly and ensure medication safety has become a key concern for patients and their families.
      501
      2025-12-16 10:38:11
    • What are the Indications of Valcyte?
      Valcyte is an important antiviral drug, with valganciclovir as its active ingredient. As a prodrug of ganciclovir, it has a specific clinical application scope and strict medication standards.
      507
      2025-12-16 10:24:40
    Contact Us
    Mailbox:Info@Lucius.La
    Welcome To Consult
    Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved